The Lancet Psychiatry
-
healthGlobal Study Finds Peripartum Depression Peaks in First Weeks After Birth
A global review of over two million women reveals peripartum depression is highest postpartum, with significant regional variation.
-
healthCannabis Unlikely to Treat Mental Health Disorders
A major study finds no strong evidence that medicinal cannabinoids help with depression, anxiety, or PTSD, raising concerns about widespread use.
-
healthWeight-Loss Drug Semaglutide Linked to Lower Mental Health Risks
New study shows semaglutide significantly reduces risks of depression, anxiety, and self-harm in patients with obesity or diabetes.
-
healthMedical Cannabis Lacks Strong Evidence for Treating Mental Health Disorders
A major review finds insufficient evidence that medicinal cannabis effectively treats anxiety, PTSD, or psychotic disorders, highlighting urgent need for more rigorous trials.
-
healthCannabis Lacks Efficacy for Most Mental Health Conditions, Major Review Finds
A comprehensive analysis of clinical trials finds little evidence that cannabis effectively treats anxiety, PTSD, depression, or other common mental disorders.
-
techAI Chatbots Linked to Delusional Thinking in Vulnerable Users
New review in The Lancet Psychiatry warns AI chatbots may amplify delusions, especially in those prone to psychosis. Experts urge caution and clinical oversight.